Here’s Why Diamond Hill Mid Cap Composite Purchased Revvity (RVTY) in Q3

Market Performance - US stocks gained over 8% in Q3 2025, as measured by the Russell 3000 Index, with small-cap stocks rising more than 12% [1] - Large-cap stocks increased by about 8%, while mid-cap stocks saw a gain of 5% [1] Diamond Hill Mid Cap Strategy Performance - The strategy underperformed the Russell Midcap Index in Q3 2025, returning 4.49% net compared to 5.33% for the Index [1] Revvity, Inc. Overview - Revvity, Inc. (NYSE:RVTY) is a health sciences solutions, technologies, and services company with a market capitalization of $11.309 billion [2] - The stock closed at $97.43 per share on December 30, 2025, with a one-month return of -5.16% and a 52-week loss of 12.70% [2] Investment Insights on Revvity, Inc. - The company initiated several new positions in Q3 2025, including Revvity, Inc., due to its long-term growth outlook [3] - Revvity, Inc. reported revenue of $699 million in Q3 2025, resulting in 1% organic growth [4] - Despite acknowledging Revvity's potential, the company believes certain AI stocks offer greater upside potential and less downside risk [4] Hedge Fund Interest - Revvity, Inc. was held by 22 hedge fund portfolios at the end of Q3 2025, down from 27 in the previous quarter [4]